Modulation of the endocannabinoid receptor CB2 as a novel treatment for the lysosomal diseases

Publication date: February 2021Source: Molecular Genetics and Metabolism, Volume 132, Issue 2Author(s): Calogera M. Simonaro, Xingxuan He, Victor DeAngelis, Changzhi Zhu, Edward H. Schuchman

Source: Molecular Genetics and Metabolism - February 2, 2021 Category: Genetics & Stem Cells Source Type: research